Patent · US Expired

Compositions for inhalation

US6632456B1 · kind B1 · utility

51Cited by
77References
43Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 24, 1997
Grant dateOct 14, 2003
Priority date
Expiry dateOct 24, 2017

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/145
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical composition including a mixture of active compounds (A) a pharmaceutically active polypeptide, and (B) an enhancer compound which enhances the systemic absorption of the polypeptide in the lower respiratory tract of a patient, the mixture being in the form of a dry powder for inhalation in which at least 50% of the total mass of the active compounds consists of primary particles having a diameter less than or equal to about 10 microns, the primary particles optionally being formed into agglomerates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.